Corcept Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Corcept Therapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About CORT

Corcept Therapeutics, Inc. engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. 

CEO
Joseph K. Belanoff
CEOJoseph K. Belanoff
Employees
730
Employees730
Headquarters
Redwood City, California
HeadquartersRedwood City, California
Founded
1998
Founded1998
Employees
730
Employees730

CORT Key Statistics

Market cap
12.73B
Market cap12.73B
Price-Earnings ratio
289.44
Price-Earnings ratio289.44
Dividend yield
—
Dividend yield—
Average volume
735.47K
Average volume735.47K
High today
$122.81
High today$122.81
Low today
$117.42
Low today$117.42
Open price
$121.83
Open price$121.83
Volume
556.22K
Volume556.22K
52 Week high
$126.38
52 Week high$126.38
52 Week low
$28.66
52 Week low$28.66

Stock Snapshot

The current Corcept Therapeutics(CORT) stock price is $117.55, with a market capitalization of 12.73B. The stock trades at a price-to-earnings (P/E) ratio of 289.44.

On 2026-10-13, Corcept Therapeutics(CORT) stock moved within a range of $117.42 to $122.81. With shares now at $117.55, the stock is trading +0.1% above its intraday low and -4.3% below the session's peak.

Trading activity shows a volume of 556.22K, compared to an average daily volume of 735.47K.

Over the past 52 weeks, Corcept Therapeutics(CORT) stock has traded between a high of $126.38 and a low of $28.66.

Over the past 52 weeks, Corcept Therapeutics(CORT) stock has traded between a high of $126.38 and a low of $28.66.

CORT News

Zacks 14h
Are Options Traders Betting on a Big Move in Corcept Therapeutics Stock?

Investors in Corcept Therapeutics Incorporated (CORT Quick QuoteCORT - Free Report) need to pay close attention to the stock based on moves in the options...

Are Options Traders Betting on a Big Move in Corcept Therapeutics Stock?
Reuters 1d
Drugmaker Corcept seeks to bar ex-judge's views in Teva antitrust case - Reuters

...

Drugmaker Corcept seeks to bar ex-judge's views in Teva antitrust case - Reuters
Simply Wall St 6d
Corcept Therapeutics Earnings And Pipeline Buzz Put Fair Value Back In Focus

Corcept Therapeutics (CORT) is back in focus after the firm paired recent earnings momentum and product pipeline optimism with an executive shakeup in its Endoc...

Corcept Therapeutics Earnings And Pipeline Buzz Put Fair Value Back In Focus

Analyst ratings

71%

of 7 ratings
Buy
71.4%
Hold
14.3%
Sell
14.3%

People also own

Based on the portfolios of people who own CORT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.